SNPs (Single Nucleotide Polymorphisms) genotyping is the process of analyzing and screening of genetic variations of SNPs between members of a species. It is an upcoming area of interest for researchers for genomics and life science studies. SNP genotyping has a broad range of applications in a number of industries such as pharmaceuticals, research, agricultural biotechnological and others which leads to change in dairy and meat yield and crop yields. The use of SNP genotyping is growing rapidly from personalized genetic testing to plant and animal biotechnology. SNP genotyping gives an idea about the human genome characterization and transfer of hereditary diseases. SNP genotyping is of great value for the pharmaceutical and medical fields as it predicts disease association and the response of an individual for specific medication. Human SNP genotyping has lots of implications in diseases prognosis and treatment, clinical diagnostics, in new drug discovery and improving current practice of medicine.
Some of the other driving factors for this market are growing prevalence of fatal diseases such as cancer, diabetes and others, increasing demand for genetic analysis in animal and plant feedstock, presence of private and public funding programs in the field of genetics. On the basis of product, SNP genotyping market is segmented into consumables or reagent, instruments and services. Introduction of technological advancements on the grounds of accuracy, portability and cost effectiveness such as growing use of real time and multiplex PCR and massarrays system is expected to drive the market at a rapid pace. On the basis of application the market is segmented into pharmacogenomics & pharmaceuticals, diagnostic research, breeding & animal livestock and agricultural biotechnology. On the basis of technology the market is classified into taqman allelic discrimination, microarrays & SNP genechips, Sequenom Massarray, MALDI-TOF, applied biosciences SNPlex, SNP pyrosequencing and other SNP genotyping technologies. Taqman allelic discrimination is the process of identifying one and only one gene or allele with the use of DNA polymerase and ligase enzyme. Sequenom’s massarray system determines SNP by detecting molecular weight of DNA fragments.
Globally SNP genotyping market is segmented into four major regions such as Europe, North America, Asia Pacific and RoW. The North America is considered as most dominant market due to favorable government policies towards proper diagnosis, screening and treatment of fatal diseases, availability of better R&D facilities and the presence of advanced technologies. Europe and Asia Pacific market is emerging owing to the development of various plans and policies of government, rising incidences of targeted diseases, improvements in healthcare services, increasing demand for personalized medicines and rising economic development. Key players in this market area are, Sequenom, Inc., Douglas Scientific LLC, PREMIER Biosoft, Sequenom Inc., Luminex Corp., Life Technologies Corp., Fluidigm, Illumina, Inc., Affymetrix, Inc.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."